RxSight, Inc. RXST Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 77%+0.4pp | 76.6%+1.6pp | 75%+1.9pp | 73.1%+1.3pp | 71.9%+1.2pp | |
| Operating margin | -43.4%-7.6pp | -35.8%-3.8pp | -32%-3.1pp | -28.9%-4.1pp | -24.9%+1.5pp | |
| Net margin | -36.6%-7.6pp | -29%-3.8pp | -25.1%-3.2pp | -21.9%-4.0pp | -17.9%+1.7pp | |
| Returns | ||||||
| Return on equity | -17.1%-3.1pp | -14%-1.1pp | -12.9%-1.3pp | -11.7%+0.3pp | -12%+0.5pp | |
| Return on invested capital | -21.1%-3.4pp | -17.7%-0.6pp | -17.2%-0.5pp | -16.6%+1.9pp | -18.6%-1.4pp | |
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.5×0.0× | 0.5×-0.1× | 0.6×0.0× | |
| Liquidity | ||||||
| Current ratio | 10.2×-0.8× | 10.9×-1.8× | 12.7×-1.2× | 13.9×+1.2× | 12.7×+1.3× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $6.47-4.1% | $6.75+0.2% | $6.74-1.3% | $6.82-1.0% | $6.90-4.7% | |
| Valuation | ||||||
| Market capitalization | $232.23M-56.8% | $428.44M+16.5% | $367.83M-33.9% | $556.73M-45.5% | $1.02B-26.2% | |
| Price / sales | 1.8×-1.8× | 3.2×+0.6× | 2.6×-1.2× | 3.8×-3.1× | 6.9×-3.0× | |
| Price / book | 0.9×-1.1× | 1.6×+0.2× | 1.3×-0.7× | 2×-1.7× | 3.7×-1.3× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are RxSight, Inc.'s profit margins?
- RxSight, Inc. (RXST) runs a 77.0% gross margin and a -43.4% operating margin, with a -36.6% net margin.
- Where do RxSight, Inc.'s ratios come from?
- Every ratio is computed from RxSight, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
